The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cabazitaxel EVER Pharma 10 mg/ml concentrate for solution for infusion

10 milligram(s)/millilitre Concentrate for solution for infusion

EVER Valinject GmbH PA1774/004/001

Main Information

Trade NameCabazitaxel EVER Pharma 10 mg/ml concentrate for solution for infusion
Active SubstancesCabazitaxel
Strength10 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderEVER Valinject GmbH
Licence NumberPA1774/004/001

Group Information

ATC CodeL01CD04 cabazitaxel

Status

Authorised/WithdrawnAuthorised
Licence Issued11/12/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back